LNTH Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

82.000

Open

81.530

VWAP

80.69

Vol

1.01M

Mkt Cap

5.20B

Low

79.655

Amount

81.39M

EV/EBITDA(TTM)

14.39

Total Shares

64.61M

5.55B

EV/OCF(TTM)

14.22

P/S(TTM)

3.70

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. The Company's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The Company's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The Company's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The Company's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.

Events Timeline

(ET)

2026-03-06

16:10:00

Lantheus Receives FDA Approval for Pylarify TruVu Injection

2026-03-02 (ET)

2026-03-02

08:40:00

Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate

2026-02-26 (ET)

2026-02-26

07:20:00

Sees Revenue of $1.4B-$1.45B, Consensus $1.49B

News

9.5

03-09Fool

Lantheus Holdings Exceeds 2025 Financial Expectations

4.5

03-09Benzinga

U.S. Stock Futures Lower, Investors Eye Individual Stocks

5.0

03-07NASDAQ.COM

Lantheus Receives FDA Approval for New Imaging Agent

5.0

03-06stocktwits

Lantheus Holdings' PYLARIFY TruVu Injection Receives FDA Approval

5.0

03-06Newsfilter

Lantheus Launches New PSMA PET Imaging Agent PYLARIFY TruVu

7.0

03-02Businesswire

Lantheus Holdings Under Investigation for Securities Violations

7 Analyst Rating

Wall Street analysts forecast LNTH stock price to rise

6 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

70.00

Averages

82.17

High

105.00

Current: 0.000

Low

70.00

Averages

82.17

High

105.00

Truist

Buy

maintain

$82 -> $89

AI Analysis

2026-03-02

Reason

Truist

Price Target

$82 -> $89

AI Analysis

2026-03-02

maintain

Buy

Reason

Truist raised the firm's price target on Lantheus to $89 from $82 and keeps a Buy rating on the shares. The company posted a PYLARIFY-driven Q4 EPS beat and an expected below-consensus 2026 guide, with benefits from key upcoming product approvals left as upside, the analyst tells investors in a research note. Truist adds it sees compelling growth re-acceleration prospects in the second half of the year and a return to the double-digit growth in FY27.

Mizuho

Anthony Petrone

Outperform

maintain

$72 -> $85

2026-02-27

Reason

Mizuho

Anthony Petrone

Price Target

$72 -> $85

2026-02-27

maintain

Outperform

Reason

Mizuho analyst Anthony Petrone raised the firm's price target on Lantheus to $85 from $72 and keeps an Outperform rating on the shares post the Q4 report. The company is growing Pylarify volumes, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LNTH

Unlock Now

Valuation Metrics

The current forward P/E ratio for Lantheus Holdings Inc (LNTH.O) is 13.30, compared to its 5-year average forward P/E of 18.11. For a more detailed relative valuation and DCF analysis to assess Lantheus Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

18.11

Current PE

13.30

Overvalued PE

28.76

Undervalued PE

7.46

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

10.11

Current EV/EBITDA

9.39

Overvalued EV/EBITDA

14.12

Undervalued EV/EBITDA

6.09

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.83

Current PS

3.06

Overvalued PS

4.74

Undervalued PS

2.92

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

any good trades for today

Intellectia · 40 candidates

Price: $5.00 - $100.00Volume: >= 1,000,000Price Change Pct: $3.00 - $15.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20

Ticker

Name

Market Cap$

DYN

Dyne Therapeutics Inc

2.45B

AXTI

AXT Inc

1.79B

SLDB

Solid Biosciences Inc

525.89M

CAPR

Capricor Therapeutics Inc

1.52B

ICL

ICL Group Ltd

6.38B

TALK

Talkspace Inc

788.52M

2 great growth stocks

Intellectia · 63 candidates

Market Cap: >= 5.00BRegion: USAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 15Eps 5yr Cagr: >= 15Pe Ttm: 10 - 60List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

HOOD

Robinhood Markets Inc

69.80B

SCHW

Charles Schwab Corp

169.43B

BKNG

Booking Holdings Inc

131.86B

ATAT

Atour Lifestyle Holdings Ltd

5.66B

FUTU

Futu Holdings Ltd

21.12B

Permian Resources Corp

14.60B

list 4 promising quantum computing stocks

Intellectia · 294 candidates

Market Cap: >= 500.00MBeta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 0

Ticker

Name

Market Cap$

LBRDA

Liberty Broadband Corp

6.25B

FRHC

Freedom Holding Corp

7.61B

CIVI

Civitas Resources Inc

2.32B

DLO

Dlocal Ltd

3.98B

OWL

Blue Owl Capital Inc

24.58B

CCB

Coastal Financial Corp (EVERETT)

1.73B

Whales Holding LNTH

Polaris Capital Management, LLC

Portolan Capital Management, LLC

Vestal Point Capital, LP

Reinhart Partners, LLC

Deerfield Management Company, L.P.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Lantheus Holdings Inc (LNTH) stock price today?

The current price of LNTH is 80.42 USD — it has decreased -2.69

What is Lantheus Holdings Inc (LNTH)'s business?

What is the price predicton of LNTH Stock?

Wall Street analysts forecast LNTH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LNTH is82.17 USD with a low forecast of 70.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Lantheus Holdings Inc (LNTH)'s revenue for the last quarter?

Lantheus Holdings Inc revenue for the last quarter amounts to 406.79M USD, increased 4.01

What is Lantheus Holdings Inc (LNTH)'s earnings per share (EPS) for the last quarter?

Lantheus Holdings Inc. EPS for the last quarter amounts to 0.81 USD, decreased -576.47

How many employees does Lantheus Holdings Inc (LNTH). have?

Lantheus Holdings Inc (LNTH) has 1193 emplpoyees as of March 13 2026.

What is Lantheus Holdings Inc (LNTH) market cap?

Today LNTH has the market capitalization of 5.20B USD.

LNTH Overview

LNTH Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding LNTH

Trading Trends

People Also Watch

Frequently Asked Questions

What is Lantheus Holdings Inc (LNTH) stock price today?

What is Lantheus Holdings Inc (LNTH)'s business?

What is the price predicton of LNTH Stock?

What is Lantheus Holdings Inc (LNTH)'s revenue for the last quarter?

What is Lantheus Holdings Inc (LNTH)'s earnings per share (EPS) for the last quarter?

How many employees does Lantheus Holdings Inc (LNTH). have?

What is Lantheus Holdings Inc (LNTH) market cap?